By Trey Brasher Beta-blockers are a class of drugs most commonly prescribed for reducing hypertension (lowering blood pressure) and widely considered one of the
Last month, we had the honor of welcoming Dr. Gunther Weil, the only remaining member of the Harvard Psilocybin Project, to speak to our
By Trey Brasher & David Rosen, Ph.D. | 22 minute read Few discoveries in history have changed psychology more than the 1943
Psychedelics continue to prove their therapeutic value, making them beneficial tools for healing and transformational work. Most likely, if you’re reading this you share this
By Trey Brasher | 14 minute read On April 19th, 1943 in Basil, Switzerland, chemist Albert Hofmann took the world’s first trip on LSD. The
Psychedelics have found their way to the forefront of conversations like never before. As more states and countries move to decriminalize low-level possession and
By Trey Brasher | 10 min read In modern society, the drive for altered consciousness is most frequently treated as pathology. Although undoubtedly
Research Director Matthew Lowe is no stranger to the world of neuroscience and psychedelics. As previous Director of Research at Stanford Medical School, he
The freedom of religion guaranteed in the First Amendment has been applied to religious use of psychedelics in a number of court cases. These modern
©2023 Unlimited Sciences. All rights reserved.
Our newsletter is meant to provide you with the latest news in psychedelic research, inform you about our work, and inspire you with compelling stories from all over the world about the power of psychedelics.
